Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Dapavo, P.
59  Ergebnisse:
Personensuche X
?
1

P973 Real-world data on the effectiveness on IBD of anti-IL..:

Ribaldone, D G ; Palumbo, A ; Cariti, C...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1765-i1765 , 2024
Link: https://doi.org/10.1093/..
 
?
2

Long‐term effectiveness and tolerability of apremilast in p..:

Gargiulo, L. ; Ibba, L. ; Malagoli, P....
Journal of the European Academy of Dermatology and Venereology.  , 2024
Link: https://doi.org/10.1111/..
 
?
3

A risankizumab super responder profile identified by long‐t..:

Gargiulo, L. ; Ibba, L. ; Malagoli, P....
Journal of the European Academy of Dermatology and Venereology.  38 (2023)  1 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
4

Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab fail..:

Mastorino, L. ; Susca, S. ; Cariti, C....
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  9 - p. 1848-1853 , 2023
Link: https://doi.org/10.1111/..
 
?
5

Drug survival, effectiveness and safety of ixekizumab for m..:

Mastorino, L. ; Dapavo, P. ; Burzi, L....
Journal of the European Academy of Dermatology and Venereology.  38 (2023)  3 - p. 568-575 , 2023
Link: https://doi.org/10.1111/..
 
?
6

Impact of comorbidities in elderly and frail patients and r..:

Rosset, F. ; Mastorino, L. ; Dapavo, P...
Experimental Dermatology.  32 (2023)  7 - p. 1162-1164 , 2023
Link: https://doi.org/10.1111/..
 
?
7

'Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab fai..:

Mastorino, L. ; Ortoncelli, M. ; Dapavo, P...
Journal of the European Academy of Dermatology and Venereology.  38 (2023)  2 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
8

Real‐life comparison between secukinumab and ixekizumab in ..:

Avallone, G. ; Cariti, C. ; Dapavo, P....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  7 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
9

Risankizumab shows faster response in bio naïve than in bio..:

Mastorino, L. ; Castelli, F. ; Stroppiana, E....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  10 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
10

Atopic dermatitis, dupilumab and cancers: a case series:

Siliquini, N. ; Giura, M.T. ; Viola, R....
Journal of the European Academy of Dermatology and Venereology.  35 (2021)  10 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
11

Effectiveness of Secukinumab in the treatment of moderate–s..:

Ribero, S. ; Ramondetta, A. ; Fabbrocini, G....
Journal of the European Academy of Dermatology and Venereology.  35 (2021)  7 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
12

Comparison of Secukinumab and Ixekizumab in psoriasis: a re..:

Cariti, C. ; Dapavo, P. ; Mastorino, L....
Journal of the European Academy of Dermatology and Venereology.  36 (2021)  3 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
13

Evidence for a 'window of opportunity' in hidradenitis supp..:

Marzano, A.V. ; Genovese, G. ; Casazza, G....
British Journal of Dermatology.  184 (2020)  1 - p. 133-140 , 2020
Link: https://doi.org/10.1111/..
 
?
14

Creation of a severity index for hidradenitis suppurativa t..:

Marzano, A.V. ; Chiricozzi, A. ; Giovanardi, G....
Journal of the European Academy of Dermatology and Venereology.  34 (2020)  8 - p. 1815-1821 , 2020
Link: https://doi.org/10.1111/..
 
?
15

Consensus on the place in therapy of TNF‐α inhibitors in th..:

Gisondi, P. ; Bellinato, F. ; Conti, A....
Journal of the European Academy of Dermatology and Venereology.  34 (2020)  9 - p. , 2020
Link: https://doi.org/10.1111/..
 
1-15